Form 4: EverQuote CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
EverQuote CEO Jayme Mendal sold 14,360 shares of Class A Common Stock for a weighted average price of $19.46 per share, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Jayme Mendal, CEO and President of EverQuote, Inc., sold 14,360 shares of Class A Common Stock.
- The transaction occurred on October 20, 2025.
- The shares were sold at a weighted average price of $19.46 per share, with individual transaction prices ranging from $19.37 to $19.67.
- This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Mendal on December 17, 2024.
- Following this transaction, Mr. Mendal beneficially owns 466,772 shares of EverQuote Class A Common Stock.
Sentiment
Score: 5
Explanation: The filing reports a routine insider sale under a pre-arranged 10b5-1 trading plan, which is generally considered neutral as it does not typically reflect a change in management's outlook on the company's future performance.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
This is a routine insider transaction, common for executives to manage personal finances, diversify holdings, or for liquidity purposes, especially when executed under a pre-arranged 10b5-1 trading plan. Such plans are designed to allow insiders to sell shares without being accused of trading on material non-public information.
Stakeholder Impact
- Shareholders: A routine insider sale under a 10b5-1 plan typically has minimal direct impact on shareholders, as it is a pre-scheduled transaction and not indicative of new material information.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Rule 10b5-1 trading plan adopted by Jayme Mendal. |
| 10/20/2025 | Transaction date for the sale of 14,360 shares of Class A Common Stock. |
| 10/22/2025 | Date the Form 4 was signed by Jon Ayotte, attorney-in-fact for Jayme Mendal. |
Recommendation
holdThe filing reports a routine insider sale by the CEO under a pre-arranged 10b5-1 trading plan, which does not inherently signal a change in company fundamentals or management's long-term outlook. Such sales are common for executives for diversification or liquidity purposes and do not typically warrant a change in investment recommendation.
Keywords
EverQuote, EVER, Jayme Mendal, insider trading, Form 4, stock sale, 10b5-1 plan, CEO, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.